IL-17 Gene Ablation Does Not Impact Treg-Mediated Suppression of Graft-Versus-Host Disease after Bone Marrow Transplantation

Regulatory T cell (Treg) immunotherapy is a promising strategy for the treatment of graft rejection responses and autoimmune disorders. Our and other laboratories have shown that the transfer of highly purified CD4(+)CD25(+)Foxp3(+) natural Treg can prevent lethal graft-versus-host disease (GVHD) af...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Colonna, Lucrezia, Florek, Mareike, Leveson-Gower, Dennis B., Sega, Emanuela I., Baker, Jeanette, Smith, Aaron T., Negrin, Robert S.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2013
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3934793/
https://ncbi.nlm.nih.gov/pubmed/23921175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2013.07.024
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge